Since genetic alterations of BAP1, MITF, and POT1 are associated also to other cancer types [12,13,14,15,16,17,19,20], we propose for these patients an instrumental follow-up aimed at the possible early recognition of other associated neoplasm (Figure 6):. Here, BAP1 is linked to cancer.